Privia Health Group, Inc.

Privia Health Group, Inc.

PRVA
Privia Health Group, Inc.US flagNASDAQ Global Select
20.80
USD
-0.51
- -
2.62BMarket Cap
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
6.4
7.65
7.95
9.39
12.26
14.2
14.54
17.38
18.26
Basic EPS, GAAP
-0.03
0.08
0.3
-1.83
-0.08
0.2
0.12
0.19
0.18
Free Cash Flow per Basic Share
0.05
0.18
0.37
0.53
0.43
0.69
0.92
1.34
1.12
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
- -
-0.49
-0.18
-2.01
-1.95
-1.65
-1.49
-1.27
-1.24
Tangible Book Value per Share
- -
-0.17
0.18
2.55
3.02
3.09
3.62
2.99
3.11
Basic Weighted Avg Shares
103
103
103
103
111
117
119
122
123
Sales/Revenue/Turnover
658
786
817
966
1,357
1,658
1,736
2,123
2,247
Operating Margin (%)
0.33
2.04
3.11
-22.5
-1.41
1.25
0.98
1.61
1.62
Depreciation Expense
1
1
2
2
5
7
7
10
11
Net Income, GAAP
-3
8
31
-188
-9
23
14
23
22
Effective Tax Rate (%)
- -
13.19
- -
- -
- -
27.54
38.84
32.35
39.27
Profit Margin (%)
-0.46
1.05
3.82
-19.48
-0.63
1.39
0.83
1.08
0.97
Working Capital
- -
14
43
256
288
314
386
342
365
LT Debt
- -
40
33
43
8
5
3
7
7
Total Equity
- -
107
144
450
519
607
683
791
806
Return on Invested Capital (%)
- -
18.52
- -
- -
- -
2.61
1.6
3.16
2.89
Return on Capital (%)
- -
-296.19
- -
- -
- -
-15.6
-8.94
-14.92
-15.49
Return on Common Equity (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -

Capital Structure

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
3
2
2
LT Borrowings
- -
- -
- -
LT Finance Leases
4
7
7
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
123
124
126
Market Capitalization
3,023
2,897
2,531

Working Capital

FRC

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
971
911
966
Cash, Cash Equivalents & STI
441
480
420
Accounts Receivable, Net
499
401
514
Inventories
- -
- -
- -
Total Current Liabilities
583
569
601
Payables & Accruals
78
63
66
ST Debt
3
2
2
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
54.79%
15.73%
Free Cash Flow
- -
36.85%
49.53%
Net Income, GAAP
- -
-229.01%
59.33%
Sales/Revenue/Turnover
- -
21.57%
22.26%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
415
422
438
461
1,736
2025
480
521
580
541
2,123
2026
604
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.03
0.03
0.03
0.04
0.12
2025
0.03
0.02
0.06
0.07
0.19
2026
0.02
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

APIChat
CEO
Parth Mehrotra
Full Time Employees
1,140
Sector
Healthcare
Industry
Medical - Healthcare Information Services
Address
950 North Glebe Road Arlington VA United States of America 22203
IPO Date
Apr 28, 2021
Business
Privia Health Group, Inc. (PRVA) operates as a technology-driven national physician-enablement company in the United States, collaborating with physician practices, health plans, and health systems to optimize performance, enhance patient experiences, and drive value-based care. The company provides a comprehensive platform including Privia Cloud with electronic health records (EHR), practice management, and data analytics tools; management services organization capabilities that reduce administrative burdens; single-TIN medical groups for negotiating power and clinical integration; accountable care organization (ACO) programs that engage patients, lower utilization, and improve quality metrics; and networks for payers enabling custom contracts and population health management. It serves primary care and specialist physicians across value-based care segments, targeting medical groups, employers, payers, and patients nationwide. Founded in 2007 and headquartered in Arlington, Virginia, Privia Health supports over 1,140 employees and more than 4,500 providers in its network, focusing on both in-person and virtual care delivery. In a significant recent development, the company announced the acquisition of Evolent Health's ACO business, Evolent Care Partners, in September 2025 for $100 million in cash plus up to $13 million contingent on 2025 MSSP performance, expected to close in the fourth quarter of 2025 and expand its value-based care footprint to approximately 1.5 million attributed lives while contributing positively to adjusted EBITDA in 2026. This strategic move enhances synergies with Privia's technology platform and supports geographic expansion into new markets. Additionally, Privia reported strong 2024 financial results with $1.736 billion in revenue and raised 2025 guidance, underscoring its growth in the healthcare services industry.

Company News

APIChat
  • Is Privia Health Stock a Buy After Hedge Fund Rubicon Founders Added Over 175,000 Shares to Its Position?

  • Cross Keys Capital Advises Neurology Group of Bergen County in Its Partnership with Privia Health

  • TBRG vs. PRVA: Which Stock Is the Better Value Option?

  • Privia Health Enters New Jersey

  • TBRG or PRVA: Which Is the Better Value Stock Right Now?

  • Privia Health Group Q1 Earnings Call Highlights

  • Privia Health Group, Inc. (PRVA) Q1 2026 Earnings Call Transcript

  • Privia Health (PRVA) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

  • Privia Health (PRVA) Misses Q1 Earnings Estimates

  • Privia Health Reports First Quarter 2026 Financial Results

  • Privia Health to Report First Quarter 2026 Results on Thursday, May 7

  • JPMorgan Chase & Co. Acquires 30,845 Shares of Privia Health Group, Inc. $PRVA

  • Privia Health Earns 2026 HFMA MAP Award for Revenue Cycle Excellence

  • Privia Health Group CFO Sells $283,000 Worth of Shares to Cover Taxes

  • Wall Street Analysts See a 43.44% Upside in Privia Health (PRVA): Can the Stock Really Move This High?

  • Privia Health Group, Inc. (NASDAQ:PRVA) Given Consensus Recommendation of “Moderate Buy” by Brokerages

  • Marking National Colorectal Cancer Awareness Month, Privia Health Program Achieves 84% Colorectal Cancer Screening Rate Through Industry Collaboration

  • Wall Street Analysts Think Privia Health (PRVA) Could Surge 25.45%: Read This Before Placing a Bet

  • Privia Health Group, Inc. (PRVA) Q4 2025 Earnings Call Transcript

  • Privia Health (PRVA) Reports Q4 Earnings: What Key Metrics Have to Say